Bernard Thomas Golding,Christiane Riedinger,Roger John Griffin,Ian Robert Hardcastle,Eric Valeur,Anna Frances Watson,Martin Noble
申请号：
US13001372
公开号：
US08618158B2
申请日:
2009.06.25
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
